These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9832162)

  • 41. Molecular cloning and functional characterization of chicken brain tau: isoforms with up to five tandem repeats.
    Yoshida H; Goedert M
    Biochemistry; 2002 Dec; 41(51):15203-11. PubMed ID: 12484758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease.
    Kampers T; Pangalos M; Geerts H; Wiech H; Mandelkow E
    FEBS Lett; 1999 May; 451(1):39-44. PubMed ID: 10356980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substrate specificity analysis of microbial transglutaminase using proteinaceous protease inhibitors as natural model substrates.
    Taguchi S; Nishihama KI; Igi K; Ito K; Taira H; Motoki M; Momose H
    J Biochem; 2000 Sep; 128(3):415-25. PubMed ID: 10965040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.
    Sergeant N; David JP; Lefranc D; Vermersch P; Wattez A; Delacourte A
    FEBS Lett; 1997 Aug; 412(3):578-82. PubMed ID: 9276470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in experimental modeling of the assembly of tau filaments.
    Ko LW; DeTure M; Sahara N; Chihab R; Vega IE; Yen SH
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):125-39. PubMed ID: 15615632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sorting-out of acceptor-donor relationships in the transglutaminase-catalyzed cross-linking of crystallins by the enzyme-directed labeling of potential sites.
    Lorand L; Parameswaran KN; Velasco PT
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):82-3. PubMed ID: 1670900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of amine donor and acceptor sites for tissue type transglutaminase using a sequence from the C-terminus of human fibrillin-1 and the N-terminus of osteonectin.
    Khew ST; Panengad PP; Raghunath M; Tong YW
    Biomaterials; 2010 Jun; 31(16):4600-8. PubMed ID: 20223517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of altered solution conditions on tau conformational dynamics: Plausible implication on order propensity and aggregation.
    Jebarupa B; Muralidharan M; Srinivasu BY; Mandal AK; Mitra G
    Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):668-679. PubMed ID: 29630971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transient expression of fluorescent tau proteins promotes process formation in PC12 cells: contributions of the tau C-terminus to this process.
    Yu JZ; Kuret J; Rasenick MM
    J Neurosci Res; 2002 Mar; 67(5):625-33. PubMed ID: 11891775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of site-specific amino acid D-isomerization on β-sheet transition and fibril formation profiles of Tau microtubule-binding repeat peptides.
    Tochio N; Murata T; Utsunomiya-Tate N
    Biochem Biophys Res Commun; 2019 Jan; 508(1):184-190. PubMed ID: 30471859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormal tau-containing filaments in neurodegenerative diseases.
    Crowther RA; Goedert M
    J Struct Biol; 2000 Jun; 130(2-3):271-9. PubMed ID: 10940231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
    Fontana A; Spolaore B; Mero A; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains.
    Zhang J; Wang S; Huang W; Bennett DA; Dickson DW; Wang D; Wang R
    Mol Neurobiol; 2016 Oct; 53(8):5066-78. PubMed ID: 26386840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.
    Clark LN; Poorkaj P; Wszolek Z; Geschwind DH; Nasreddine ZS; Miller B; Li D; Payami H; Awert F; Markopoulou K; Andreadis A; D'Souza I; Lee VM; Reed L; Trojanowski JQ; Zhukareva V; Bird T; Schellenberg G; Wilhelmsen KC
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13103-7. PubMed ID: 9789048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tau protein and neurodegeneration.
    Kosik KS
    Mol Neurobiol; 1990; 4(3-4):171-9. PubMed ID: 2135393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].
    Sánchez MP; Alvarez-Tallada V; Avila J
    Rev Neurol; 2001 Jul 16-31; 33(2):169-77. PubMed ID: 11562878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles.
    Yamane A; Fukui M; Sugimura Y; Itoh M; Alea MP; Thomas V; El Alaoui S; Akiyama M; Hitomi K
    FEBS J; 2010 Sep; 277(17):3564-74. PubMed ID: 20716179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
    Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
    Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase.
    Grierson AJ; Johnson GV; Miller CC
    Neurosci Lett; 2001 Jan; 298(1):9-12. PubMed ID: 11154823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.